Submit Deal

DECHRA PHARMACEUTICALS PLC

Summary

Dechra Pharmaceuticals is a manufacturer of veterinary products. The company is listed on the London Stock Exchange.

Deals Overview

Total Deals12

Valued Deals8

Total Value£ 6.21 B

Avg. Deal Size£ 777 M

Market Context

Senior Management

Ian Page
CEO
Jesper Nordengaard
CEO
Richard Cotton
CFO

Sort

ast farma

HQ - Netherlands

Pharmaceuticals

24 Jan 2018

Investment Date

100%

Stake

£ 297 M

Deal Value

putney inc

HQ - United States

Pharmaceuticals

22 Apr 2016

Investment Date

n/a

Deal Value

apex laboratories pty ltd

HQ - Australia

Pharmaceuticals

15 Oct 2016

Investment Date

n/a

Deal Value

laboratorios vencofarma do brasil

HQ - Brazil

Pharmaceuticals

18 Dec 2018

Investment Date

100%

Stake

£ 37 M

Deal Value

med-pharmex inc

HQ - United States

Pharmaceuticals

30 Aug 2022

Investment Date

100%

Stake

£ 221 M

Deal Value

dechra pharmaceuticals plc

HQ - United Kingdom

Pharmaceuticals

16 Jan 2024

Investment Date

100%

Stake

£ 4.88 B

Deal Value

invetx

HQ - United States

Pharmaceuticals

2 Sep 2024

Investment Date

100%

Stake

£ 399 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy